Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Participants With Advanced Solid Tumors (P04722, MK-7454-004)
Clinical trial NCT00954512 · TERMINATED
Trial details
- NCT number
- NCT00954512
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-25
- Primary completion
- 2011-06-07
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.